Published in Heart on April 10, 2013
Inflammatory processes in cardiovascular disease: a route to targeted therapies. Nat Rev Cardiol (2016) 1.46
Tumour necrosis factor-α antagonism: a potential therapeutic target for prevention of arrhythmogenesis in the setting of acute myocardial infarction? Heart (2013) 1.39
Tumour necrosis factor-α is a foe for patients with acute myocardial infarction. Heart (2013) 1.06
Systemic inflammatory response following acute myocardial infarction. J Geriatr Cardiol (2015) 0.93
Platelet hemostasis in patients with metabolic syndrome and type 2 diabetes mellitus: cGMP- and NO-dependent mechanisms in the insulin-mediated platelet aggregation. Front Physiol (2015) 0.89
Etanercept attenuates myocardial ischemia/reperfusion injury by decreasing inflammation and oxidative stress. PLoS One (2014) 0.84
Risk of cardiovascular disease in inflammatory bowel disease. World J Gastrointest Pathophysiol (2014) 0.82
Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications. World J Gastroenterol (2016) 0.80
Inflammation and thrombosis in cardiovascular disease. Curr Opin Hematol (2013) 0.79
Direct Evidence that Myocardial Insulin Resistance following Myocardial Ischemia Contributes to Post-Ischemic Heart Failure. Sci Rep (2015) 0.76
Tissue necrosis factor α and targeting its receptor in ischaemic heart disease. Heart (2013) 0.76
Tumour necrosis factor-α is a foe for patients with acute myocardial infarction. Heart (2013) 0.75
LATITUDE-TIMI: is there still hope for anti-inflammatory therapy in acute myocardial infaction? J Thorac Dis (2016) 0.75
Apoptosis in ischemic heart disease. J Transl Med (2017) 0.75
Cardioprotective Effects of HuoxueAnshen Recipe against Myocardial Injuries Induced by Sleep Deprivation in Rats. Evid Based Complement Alternat Med (2017) 0.75
Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med (2000) 18.04
Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med (2004) 7.62
Minimisation: the platinum standard for trials?. Randomisation doesn't guarantee similarity of groups; minimisation does. BMJ (1998) 7.31
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum (2001) 5.87
Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation (2000) 3.66
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation (2004) 3.30
Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation (2001) 2.72
Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation (1999) 2.68
Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation (2002) 2.45
CD40 signaling and plaque instability. Circ Res (2001) 1.97
Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation (1999) 1.79
Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy. J Am Coll Cardiol (2002) 1.67
Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest (2003) 1.61
Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation. Circulation (2004) 1.60
Effect of the soluble TNF-antagonist etanercept on tumor necrosis factor bioactivity and stability. Clin Transl Sci (2008) 1.53
Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease. Clin Sci (Lond) (2006) 1.51
Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation (2001) 1.50
Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans. Arterioscler Thromb Vasc Biol (2003) 1.18
Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure. Circulation (2001) 1.17
Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation. Am J Physiol (1994) 1.17
Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: methodological considerations. Thromb Haemost (2007) 1.10
Cytokine mRNA expression in human platelets and a megakaryocytic cell line and cytokine modulation of platelet function. Cytokine (1997) 1.09
Tumor necrosis factor-alpha as trigger of platelet activation in patients with heart failure. Blood (2005) 0.98
The expression of TNF-alpha converting enzyme at the site of ruptured plaques in patients with acute myocardial infarction. Eur J Clin Invest (2008) 0.93
Clopidogrel reduces platelet-leucocyte aggregation, monocyte activation and RANTES secretion in type 2 diabetes mellitus. Heart (2006) 0.92
Tumor necrosis factor alpha in patients with acute myocardial infarction. Egypt J Immunol (2004) 0.90
Changes in the effects of interleukin-1beta and tumor necrosis factor-alpha on platelet activation in early pregnancy. Platelets (2001) 0.85
Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease. N Engl J Med (2007) 4.98
A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med (2005) 4.93
Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation (2005) 4.71
Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med (2008) 4.57
Global association of air pollution and heart failure: a systematic review and meta-analysis. Lancet (2013) 3.57
Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA (2011) 3.56
In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol (2013) 3.43
Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part Fibre Toxicol (2005) 3.12
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol (2012) 3.03
Adverse cardiovascular effects of air pollution. Nat Clin Pract Cardiovasc Med (2008) 3.00
Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med (2008) 2.84
Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol (2011) 2.66
Persistent endothelial dysfunction in humans after diesel exhaust inhalation. Am J Respir Crit Care Med (2007) 2.65
Expert consensus on peri-operative myocardial injury screening in noncardiac surgery: A literature review. Eur J Anaesthesiol (2021) 2.57
Omega 3 fatty acids and cardiovascular disease--fishing for a natural treatment. BMJ (2004) 2.47
Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension (2006) 2.29
The ROSE (risk stratification of syncope in the emergency department) study. J Am Coll Cardiol (2010) 2.22
Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation (2011) 2.21
Randomized controlled trial of dual antiplatelet therapy in patients undergoing surgery for critical limb ischemia. Ann Surg (2010) 2.06
Reducing personal exposure to particulate air pollution improves cardiovascular health in patients with coronary heart disease. Environ Health Perspect (2012) 2.05
Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study. BMJ (2012) 2.02
Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 2.01
Diesel exhaust inhalation increases thrombus formation in man. Eur Heart J (2008) 1.96
Vascular dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 1.87
Diesel exhaust inhalation does not affect heart rhythm or heart rate variability. Heart (2010) 1.84
Combustion-derived nanoparticulate induces the adverse vascular effects of diesel exhaust inhalation. Eur Heart J (2011) 1.79
Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circ Cardiovasc Interv (2010) 1.75
Genome-wide analysis of the structural genes regulating defense phenylpropanoid metabolism in Populus. New Phytol (2006) 1.73
Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am J Respir Crit Care Med (2005) 1.72
In vivo association between positive coronary artery remodelling and coronary plaque characteristics assessed by intravascular optical coherence tomography. Eur Heart J (2008) 1.69
Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnoea: a randomized placebo-controlled trial. Eur Heart J (2007) 1.68
Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy. J Am Coll Cardiol (2002) 1.67
Are our medical graduates in New Zealand safe and accurate in ECG interpretation? N Z Med J (2009) 1.61
Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes. Diabetes Care (2010) 1.57
Exposure to diesel exhaust induces changes in EEG in human volunteers. Part Fibre Toxicol (2008) 1.54
Calcific aortic stenosis: a disease of the valve and the myocardium. J Am Coll Cardiol (2012) 1.52
Prevalence of coronary artery calcification in patients undergoing assessment for orthotopic liver transplantation. Liver Transpl (2008) 1.52
Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease. Clin Sci (Lond) (2006) 1.51
Non-invasive measurement of cardiac output in patients with chronic heart failure. Blood Press Monit (2004) 1.51
Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans. J Am Coll Cardiol (2008) 1.47
Reduced vascular complications and length of stay with transradial rescue angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv (2007) 1.46
Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension (2009) 1.46
Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study. Am Heart J (2004) 1.45
Exposure to concentrated ambient particles does not affect vascular function in patients with coronary heart disease. Environ Health Perspect (2008) 1.45
Beneficial cardiovascular effects of reducing exposure to particulate air pollution with a simple facemask. Part Fibre Toxicol (2009) 1.45
Characterisation and reproducibility of a human ex vivo model of thrombosis. Thromb Res (2010) 1.43
The constituents and mechanisms of generation of 'endothelial cell--colony forming units'. Cardiovasc Res (2013) 1.41
Same-day discharge is feasible and safe in the majority of elderly patients undergoing elective percutaneous coronary intervention. J Invasive Cardiol (2010) 1.41
Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarction. Thromb Res (2005) 1.39
Abdominal aortic aneurysm growth predicted by uptake of ultrasmall superparamagnetic particles of iron oxide: a pilot study. Circ Cardiovasc Imaging (2011) 1.33
Vascular effects of apelin in vivo in man. J Am Coll Cardiol (2008) 1.33
Ultrasmall superparamagnetic particles of iron oxide in patients with acute myocardial infarction: early clinical experience. Circ Cardiovasc Imaging (2012) 1.32
Air pollution and atherothrombosis. Inhal Toxicol (2007) 1.30
In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humans. Circ Cardiovasc Imaging (2012) 1.29
Direct impairment of vascular function by diesel exhaust particulate through reduced bioavailability of endothelium-derived nitric oxide induced by superoxide free radicals. Environ Health Perspect (2008) 1.25
Increased platelet activation in patients with stable and acute exacerbation of COPD. Thorax (2011) 1.25
Stimulated tissue plasminogen activator release as a marker of endothelial function in humans. Arterioscler Thromb Vasc Biol (2005) 1.24
Exposure to nitrogen dioxide is not associated with vascular dysfunction in man. Inhal Toxicol (2010) 1.23
Heat and haze: a forecast for myocardial infarction? Heart (2009) 1.22
Impaired vascular function after exposure to diesel exhaust generated at urban transient running conditions. Part Fibre Toxicol (2010) 1.20
Differential expression of two distinct phenylalanine ammonia-lyase genes in condensed tannin-accumulating and lignifying cells of quaking aspen. Plant Physiol (2002) 1.19
Particle traps prevent adverse vascular and prothrombotic effects of diesel engine exhaust inhalation in men. Circulation (2011) 1.19
Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans. Arterioscler Thromb Vasc Biol (2003) 1.18
The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential. Biochem Pharmacol (2008) 1.18
Influence of the menstrual cycle, pregnancy, and preeclampsia on arterial stiffness. Hypertension (2009) 1.16
Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2012) 1.15
Endothelial fibrinolytic capacity predicts future adverse cardiovascular events in patients with coronary heart disease. Arterioscler Thromb Vasc Biol (2007) 1.14
Recycling between cortisol and cortisone in human splanchnic, subcutaneous adipose, and skeletal muscle tissues in vivo. Diabetes (2012) 1.13
Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography. Catheter Cardiovasc Interv (2003) 1.12
Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD. Eur Respir J (2012) 1.12
Differential expansion and expression of alpha- and beta-tubulin gene families in Populus. Plant Physiol (2007) 1.12
The sucrose transporter family in Populus: the importance of a tonoplast PtaSUT4 to biomass and carbon partitioning. Plant J (2011) 1.11